San Antonio Business Journal: Alamo City research contributes to potential new COVID vaccine

Dr. Barbara Taylor, Infectious Diseases, and the great work of the Novavax research team of UT Health San Antonio and University Health, are featured in the San Antonio Business Journal. The local site of the international clinical trial by the COVID-19 Prevention Network enrolled more than 175 participants.

Read the story.

Share This Article!